ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 195,500
-4,500 (-2.25%)
Jan 2, 2026, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 11.03 trillion as of December 31, 2025. Its market cap has increased by 727.34% in one year.
Market Cap
11.03T
Enterprise Value
10.94T
Revenue
88.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
195,500.00
Market Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 11.03T, an increase of 1,711.50%. That is a compound annual growth rate of 50.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 11.03T | 663.70% |
| Dec 30, 2024 | 1.44T | 22.53% |
| Dec 28, 2023 | 1.18T | 7.19% |
| Dec 29, 2022 | 1.10T | 5.54% |
| Dec 30, 2021 | 1.04T | -27.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.46T |
| Celltrion | 39.60T |
| ALTEOGEN | 24.04T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.39T |
| HLB Co., Ltd. | 6.69T |
| LigaChem Biosciences | 6.32T |
| Peptron | 5.92T |